ATE21173T1 - Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen. - Google Patents

Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.

Info

Publication number
ATE21173T1
ATE21173T1 AT82850077T AT82850077T ATE21173T1 AT E21173 T1 ATE21173 T1 AT E21173T1 AT 82850077 T AT82850077 T AT 82850077T AT 82850077 T AT82850077 T AT 82850077T AT E21173 T1 ATE21173 T1 AT E21173T1
Authority
AT
Austria
Prior art keywords
fluorescence
lantanide
chelate
biologically active
active substances
Prior art date
Application number
AT82850077T
Other languages
English (en)
Inventor
Ilkka Hemmilae
Salifu Dakubu
Original Assignee
Wallac Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wallac Oy filed Critical Wallac Oy
Application granted granted Critical
Publication of ATE21173T1 publication Critical patent/ATE21173T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/40—Rare earth chelates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
AT82850077T 1981-04-30 1982-04-08 Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen. ATE21173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8102753A SE425439B (sv) 1981-04-30 1981-04-30 Immunologisk analys med lantanidkelatkomplex som markor
EP82850077A EP0064484B1 (de) 1981-04-30 1982-04-08 Methode zur fluoreszenz-spektroskopischen Bestimmung von biologisch aktiven Substanzen

Publications (1)

Publication Number Publication Date
ATE21173T1 true ATE21173T1 (de) 1986-08-15

Family

ID=20343715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82850077T ATE21173T1 (de) 1981-04-30 1982-04-08 Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.

Country Status (6)

Country Link
US (1) US4565790A (de)
EP (2) EP0159066A1 (de)
JP (1) JPS57186170A (de)
AT (1) ATE21173T1 (de)
DE (1) DE3272260D1 (de)
SE (1) SE425439B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301395L (sv) * 1983-03-15 1984-09-16 Wallac Oy Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
US4629693A (en) * 1984-03-27 1986-12-16 Syntex (U.S.A.) Inc. Sensitivity in fluorescence assays in icteric samples
US4761481A (en) * 1985-03-18 1988-08-02 Baxter Travenol Laboratories, Inc. Substituted pyridine derivatives
US5830769A (en) * 1985-03-18 1998-11-03 Wieder; Irwin Homogeneous fluorassay methods employing fluorescent background rejection and water-soluble rare earth metal chelates
SE8502573D0 (sv) * 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
IT1186733B (it) * 1985-06-05 1987-12-16 Eniricerche Spa Composti tripeptidici ad azione ipotensiva
US5155216A (en) * 1985-08-15 1992-10-13 Amoco Corporation Nucleic acids labeled with a chemiluminescent acridine ester
WO1987002708A1 (en) * 1985-10-24 1987-05-07 Siska Diagnostics, Inc. Lanthanide chelate-tagged nucleic acid probes
US5585279A (en) * 1986-01-23 1996-12-17 Davidson; Robert S. Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
GB8601646D0 (en) * 1986-01-23 1986-02-26 Davidson R S Binding assay & reagent
US4727024A (en) * 1986-05-12 1988-02-23 Martin Koocher Binding assays involving formation and detection of light scattering crystals
US4925804A (en) * 1986-06-17 1990-05-15 Baxter International Inc. Interligand metal transfer assay
EP0272320B1 (de) 1986-06-17 1994-03-23 Baxter Diagnostics Inc. Homogenes fluortestverfahren mit abstoss des fluorzenten hintergrundes.
GB8622855D0 (en) * 1986-09-23 1986-10-29 Ekins R P Determining biological substance
SE8703682L (sv) * 1987-09-24 1989-03-25 Wallac Oy Homogen bestaemningsmetod som utnyttjar affinitetsreaktioner
US4978625A (en) * 1987-10-19 1990-12-18 Becton, Dickinson And Company Fluorescence immunoassay using water insoluble dyes
AU2714988A (en) * 1987-10-23 1989-06-01 Siska Diagnostics, Inc. Lanthanide chelate-tagged nucleic acid probes
EP0493745A1 (de) * 1990-12-21 1992-07-08 Dojindo Laboratories Fluoreszierende Verbindung, Komplex, Reagenz und spezifische Bindungtest
FI88545C (fi) * 1991-03-12 1993-05-25 Jouko Kankare Bestaemningsmetod
US5792330A (en) * 1995-05-31 1998-08-11 Board Of Regents, The University Of Texas System Lanthanide metal cations for concurrent detection and separation in capillary electrophoresis
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7070921B2 (en) 2000-04-28 2006-07-04 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US6030840A (en) * 1998-06-15 2000-02-29 Nen Life Sciences, Inc. Neutral enhancement of lanthanides for time resolved fluorescence
US6838292B1 (en) 1999-04-19 2005-01-04 Alion Science And Technology Corporation Detection of biological warfare agents
AU3081801A (en) 1999-11-15 2001-05-30 Chemclean Corporation Bio-burden visualization system
JP4545337B2 (ja) * 2001-03-23 2010-09-15 オリンパス株式会社 顕微鏡
WO2003003063A2 (en) * 2001-06-28 2003-01-09 Ia, Inc. Fiber-optic sensor array
JP4117248B2 (ja) * 2001-10-10 2008-07-16 株式会社日立ハイテクノロジーズ 発光性化合物及びそれを用いた標識試薬
US7211440B2 (en) * 2002-03-08 2007-05-01 Wallac Oy Dissociative fluorescence enhancement assay
WO2006039505A2 (en) * 2004-09-30 2006-04-13 Molecular Devices Corporation Luminescent lanthanide complexes
US20060166376A1 (en) * 2005-01-21 2006-07-27 Craig Alan R Compositions for use as a signal generation component and methods of using same
US7482444B2 (en) * 2006-03-13 2009-01-27 Wallac Oy Terminating substrates for DNA polymerases
US8778614B2 (en) 2010-08-24 2014-07-15 Enzo Life Sciences, Inc. Assays for detecting modified compounds
CN103969432B (zh) * 2014-03-27 2016-02-17 中国科学院福建物质结构研究所 一种稀土纳米材料溶解增强时间分辨荧光免疫分析方法
US9834808B2 (en) 2016-01-21 2017-12-05 SeLux Diagnostics, Inc. Methods for rapid antibiotic susceptibility testing
WO2017127684A1 (en) 2016-01-21 2017-07-27 SeLux Diagnostics, Inc. Methods for rapid antimicrobial susceptibility testing
BR112019012979A2 (pt) 2016-12-23 2019-12-31 Selux Diagnostics Inc métodos para o teste de suscetibilidade antimicrobiana rápida melhorada
AU2020340381A1 (en) 2019-08-27 2022-04-07 SeLux Diagnostics, Inc. Systems and methods for performing antimicrobial susceptibility testing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058732A (en) * 1975-06-30 1977-11-15 Analytical Radiation Corporation Method and apparatus for improved analytical fluorescent spectroscopy
US4341957A (en) * 1975-11-26 1982-07-27 Analytical Radiation Corporation Fluorescent antibody composition for immunofluorometric assay
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
US4283382A (en) * 1977-12-28 1981-08-11 Eastman Kodak Company Fluorescent labels comprising rare earth chelates
US4259313A (en) * 1978-10-18 1981-03-31 Eastman Kodak Company Fluorescent labels

Also Published As

Publication number Publication date
EP0159066A1 (de) 1985-10-23
JPH049263B2 (de) 1992-02-19
JPS57186170A (en) 1982-11-16
US4565790A (en) 1986-01-21
EP0064484B1 (de) 1986-07-30
SE425439B (sv) 1982-09-27
EP0064484A3 (en) 1983-01-19
EP0064484A2 (de) 1982-11-10
DE3272260D1 (en) 1986-09-04

Similar Documents

Publication Publication Date Title
ATE21173T1 (de) Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.
DE69132098D1 (de) Verfahren zur amplifikation von nukleinsäuren
DE59008475D1 (de) Verwendung eines schwer löslichen Salzes einer Heteropolysäure zur Bestimmung eines Analyts, entsprechendes Bestimmungsverfahren sowie hierfür geeignetes Mittel.
DE69022786T2 (de) Verfahren zur Bestimmung der Konzentration von Glucose.
FI904534A0 (fi) Foerfarande och anordning foer amperometrisk diagnosanalys.
ATE114334T1 (de) Chaotropisches verfahren zur schätzung von nukleinen säuren in einer biologischen probe.
FI895959A0 (fi) Komposition, diagnostisk bruksfoerpackning och foerfarande foer snabb detektering av antikroppar.
ATE26002T1 (de) Verfahren zur gleichzeitigen bestimmung von fibrinogen und fibrinogen-spaltprodukten im plasma.
DE69401717T2 (de) Verfahren zur Aktivierung von polyanionischen,fluoreszierenden Farbstoffen in schwach dielektrischen Medien mit quaternären Oniumverbindungen
DE3779706T2 (de) Enzymsensor zur bestimmung von glutaminat-konzentration.
DE3788762T2 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
ATE97791T1 (de) Vorrichtung zur bestimmung der konzentration von zumindest einer in organischem gewebe vorliegenden substanz.
ATE17262T1 (de) Verfahren zur quantitativen bestimmung von blutgerinnungsfaktor xii in humanplasma.
DE69833660D1 (de) Nukleinsäuresonden zur detektion von candida-spezies
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
ATE20498T1 (de) Verfahren zur bestimmung des ph-wertes im innern einer zelle.
JPS5598359A (en) Removing method of non-characteristic obstacle operation in immunity determination method
ATE56097T1 (de) Mittel zur bestimmung von peroxidase-aktivitaet, verfahren zur herstellung und seine verwendung.
ATE139848T1 (de) Haaranalyse
DE3854096D1 (de) Verfahren zur Isolierung von Basalmembranproteinen aus menschlichen und tierischen Geweben.
EP0259073A3 (de) Biotests für enzyminduzierende Chemikalien auf Basis von Antikörpern
ATA144399A (de) Verfahren zur herstellung eines qualitätsgesicherten pools biologischer proben
CA2004068A1 (en) Hair analysis method
ATE74436T1 (de) Verfahren zur messung polarisierter fluoreszenzemission.
SU940568A1 (ru) Способ полярографического определения нескольких элементов при их совместном присутствии в объекте

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time